Mit grünem Wasserstoff in kurzer Zeit einen großen Schritt näher an die gesetzten Umweltziele. | Jetzt mehr erfahren-w-
18.10.2021 21:30

Worldwide Nutraceuticals Industry to 2026 - Innovations and Findings of Function-Specific Antioxidants Presents Opportunities


DUBLIN, Oct. 18, 2021 /PRNewswire/ -- The "Nutraceuticals Market Research Report by Form, Functional Ingredient, Product, Health Benefits, Distribution Channel, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to's offering.

Research and Markets Logo

The Global Nutraceuticals Market size was estimated at USD 222.34 billion in 2020, is expected to reach USD 242.75 billion in 2021, and projected to grow at a CAGR of 9.26% reaching USD 378.30 billion by 2026.

Market Statistics

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Competitive Strategic Window

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nutraceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nutraceuticals Market, including Ajinomoto Co., Inc., Archer Daniels Midland Company, Arla Foods A.m.b.A, Associated British Foods PLC, BASF SE, Cargill Incorporated, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Fonterra Co-Operative Group Limited, Glanbia PLC, Ingredion Incorporated, Kerry Group PLC, Koninklijke DSM N.V., Kyowa Kirin Co., Ltd., and Tate & Lyle PLC.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Nutraceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nutraceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nutraceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Nutraceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Nutraceuticals Market?
6. What is the market share of the leading vendors in the Global Nutraceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Nutraceuticals Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increased Life Expectancy and Health Awareness among Consumers
5.2.2. Growing Demand for Nutraceuticals with Medical Benefits
5.2.3. Growing Preference for Personalized Nutrition
5.3. Restraints
5.3.1. Low Awareness about Nutraceuticals and Higher Costs of Fortified and Enriched Products
5.4. Opportunities
5.4.1. Innovations and Findings of Function-Specific Antioxidants
5.4.2. Gradual Adoption of Probiotic and Prebiotic Food Products as Part of Personalized Diet
5.5. Challenges
5.5.1. High R&D Cost of Development
5.5.2. Varying Regulatory Standards across Different Countries

6. Nutraceuticals Market, by Form
6.1. Introduction
6.2. Dry
6.3. Liquid

7. Nutraceuticals Market, by Functional Ingredient
7.1. Introduction
7.2. Carotenoids
7.3. Dietary Fibers
7.4. Fatty Acids
7.5. Minerals
7.6. Prebiotics & Probiotics
7.7. Vitamins

8. Nutraceuticals Market, by Product
8.1. Introduction
8.2. Dietary Supplements
8.3. Functional Beverages
8.3.1. Dairy & Dairy Alternative Beverage
8.3.2. Energy Drink
8.3.3. Fortified Juice
8.3.4. Sports Drink
8.4. Functional Foods
8.4.1. Bakery and Confectionary
8.4.2. Cereal
8.4.3. Dairy
8.4.4. Snack

9. Nutraceuticals Market, by Health Benefits
9.1. Introduction
9.2. Bone Health
9.3. Cognitive Health
9.4. Gut Health
9.5. Heart Health
9.6. Immunity
9.7. Nutrition
9.8. Weigh Management

10. Nutraceuticals Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online

11. Americas Nutraceuticals Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Nutraceuticals Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand

13. Europe, Middle East & Africa Nutraceuticals Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, by Quadrant
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Ajinomoto Co., Inc.
15.2. Archer Daniels Midland Company
15.3. Arla Foods A.m.b.A
15.4. Associated British Foods PLC
15.5. BASF SE
15.6. Cargill Incorporated
15.7. Chr. Hansen Holding A/S
15.8. DuPont de Nemours, Inc.
15.9. Fonterra Co-Operative Group Limited
15.10. Glanbia PLC
15.11. Ingredion Incorporated
15.12. Kerry Group PLC
15.13. Koninklijke DSM N.V.
15.14. Kyowa Kirin Co., Ltd.
15.15. Tate & Lyle PLC

16. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

Jetzt noch kostenlos anmelden!

Während sich das Jahr dem Ende entgegenneigt, entspannen sich weltweit die Börsen, trotz Konjunktur- und Inflationssorgen. Alle Börsianer hoffen, sich jetzt noch Wertpapiere zu sichern, die eine interessante Rendite im nächsten Jahr erzielen könnten. Im Trading-Seminar heute um 18 Uhr verraten Ihnen zwei Börsenexperten exklusiv die Favoriten für das Jahr 2022!
Schnell noch kostenlos anmelden!
Börse Stuttgart Anlegerclub

Heute im Fokus

Corona-Sorgen: DAX unter Druck -- Moderna-CEO warnt vor geringerer Impfstoff-Wirksamkeit bei Omikron -- Nordex erhält Auftrag in Brasilien -- KION, VW, EVOTEC, Schneider Electric im Fokus

Britische Kartellwächter: Facebook-Konzern soll Giphy verkaufen. Deutsches Verfassungsgericht billigt Ausgangsbeschränkungen und Schulschließungen. SynBiotic will Profit aus Cannabis-Legalisierung in Deutschland ziehen. Bayer will bei Onkologie bis 2030 Spitzenposition einnehmen. ADLER Group bestätigt Prognose.


Wie bewerten Sie die Verhandlungsergebnisse und künftigen Pläne der Ampelkoalition? zero zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln